Inst Diagnosti (INDISA) — Capital Reinvestment Ratio

Latest as of June 2023: 0.20x

Inst Diagnosti (INDISA) has a Capital Reinvestment Ratio of 0.20x as of June 2023, meaning it reinvests 0% of its operating cash flow (CL$8.87 Billion) in capital expenditures (CL$1.74 Billion). Check tangible equity quality of Inst Diagnosti to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.20x
Capex / Operating Cash Flow

Operating Cash Flow

CL$8.87 Billion
CLP

Capital Expenditures

CL$1.74 Billion
CLP

Data as of

Jun 2023
Most recent filing

Inst Diagnosti Capital Reinvestment Ratio (2014–2021)

This chart tracks Inst Diagnosti's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Inst Diagnosti.

Annual Capital Reinvestment Ratio for Inst Diagnosti (2014–2021)

Year-by-year Capital Reinvestment Ratio for Inst Diagnosti from 2014 to 2021. See Inst Diagnosti (INDISA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CLP) Capital Expenditures YoY Change
2021 2.12x CL$14.83 Billion CL$31.45 Billion ▲ +146.2%
2020 0.86x CL$14.46 Billion CL$12.45 Billion ▲ +23.4%
2019 0.70x CL$10.66 Billion CL$7.44 Billion ▲ +118.0%
2018 0.32x CL$14.75 Billion CL$4.72 Billion ▼ -44.8%
2017 0.58x CL$14.89 Billion CL$8.63 Billion ▼ -31.0%
2016 0.84x CL$11.57 Billion CL$9.73 Billion ▲ +2.9%
2015 0.82x CL$15.05 Billion CL$12.30 Billion ▲ +84.0%
2014 0.44x CL$13.58 Billion CL$6.03 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow